- Home
- CATX vs LFCR Comparison
CATX vs LFCR Comparison
Compare CATX & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- LFCR
- Stock Information
- Founded
- CATX 1983
- LFCR 1986
- Country
- CATX United States
- LFCR United States
- Employees
- CATX N/A
- LFCR N/A
- Industry
- CATX Medical/Dental Instruments
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- CATX Health Care
- LFCR Health Care
- Exchange
- CATX Nasdaq
- LFCR Nasdaq
- Market Cap
- CATX 239.0M
- LFCR 255.1M
- IPO Year
- CATX N/A
- LFCR N/A
- Fundamental
- Price
- CATX $2.73
- LFCR $7.19
- Analyst Decision
- CATX Strong Buy
- LFCR Buy
- Analyst Count
- CATX 10
- LFCR 4
- Target Price
- CATX $12.30
- LFCR $8.00
- AVG Volume (30 Days)
- CATX 1.7M
- LFCR 167.9K
- Earning Date
- CATX 11-10-2025
- LFCR 11-06-2025
- Dividend Yield
- CATX N/A
- LFCR N/A
- EPS Growth
- CATX N/A
- LFCR N/A
- EPS
- CATX N/A
- LFCR N/A
- Revenue
- CATX $1,235,000.00
- LFCR $128,867,000.00
- Revenue This Year
- CATX N/A
- LFCR $4.72
- Revenue Next Year
- CATX N/A
- LFCR $10.97
- P/E Ratio
- CATX N/A
- LFCR N/A
- Revenue Growth
- CATX N/A
- LFCR 0.47
- 52 Week Low
- CATX $1.60
- LFCR $4.76
- 52 Week High
- CATX $12.90
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- CATX 36.42
- LFCR 57.46
- Support Level
- CATX $2.60
- LFCR $6.61
- Resistance Level
- CATX $3.15
- LFCR $7.37
- Average True Range (ATR)
- CATX 0.36
- LFCR 0.25
- MACD
- CATX -0.15
- LFCR 0.08
- Stochastic Oscillator
- CATX 5.12
- LFCR 82.69
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.